Skip to content

ComPro Pharma: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ComPro Pharma

BE 0746.429.351
NACE 72.101, Research and development on biotechnology
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€54,298
2024 · €56,892-€2,593
Equity
€9,170
2024 · €8,872+€298
Cash
€29,894
2024 · €50,853-€20,959
Balance sheet total
€76,879
2024 · €82,033-€5,154

Largest movements

2024 to 2025
Assets
  • Financial fixed assets +€23,000

    new in 2025: €23,000

  • Cash -€20,959

    down €20,959 (-41.2%), from €50,853 to €29,894

    mainly Contributions, distributions and other (-€54,000) and Investment in fixed assets (net) (-€24,162)

  • Tangible fixed assets -€6,086

    down €6,086 (-46.9%), from €12,982 to €6,896

  • Deferred charges and accrued income -€1,109

    down €1,109 (-49.8%), from €2,226 to €1,117

Equity and liabilities
  • Tax, wage and social debts -€4,424

    down €4,424 (-27.3%), from €16,178 to €11,754

    of which Taxes: -€4,424

  • Other debts -€1,000

    down €1,000 (-1.8%), from €55,000 to €54,000

  • Trade debts -€842

    down €842 (-42.5%), from €1,980 to €1,139

Income statement
  • Depreciation +€5,419

    up €5,419 (+296.4%), from €1,829 to €7,248

  • Gross operating margin +€2,683

    up €2,683 (+3.6%), from €75,112 to €77,795

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €56,892
Gross operating margin +€2,683
Depreciation -€5,419
Other operating charges +€411
Financial income -€699
Financial charges -€3
Taxes +€434
Result 2025 €54,298

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€56,390
Investment -€24,162
Financing -€53,187
Cash 2024 €50,853
Net result for the year +€54,298
Depreciation +€7,248
Deferred charges and accrued income +€1,109
Trade debts -€842
Tax, wage and social debts -€4,424
Other debts -€1,000
Investment in fixed assets (net) -€24,162
Short-term financial debts +€813
Contributions, distributions and other -€54,000
Cash 2025 €29,894
Every line side by side 37 lines
Line Code 2024 2025 Change %
Total assets 20/58 €82,033 €76,879 -€5,154 -6.3%
Fixed assets 21/28 €12,982 €29,896 +€16,914 +130.3%
Tangible fixed assets 22/27 €12,982 €6,896 -€6,086 -46.9%
Furniture and vehicles 24 €12,982 €6,896 -€6,086 -46.9%
Financial fixed assets 28 - €23,000 +€23,000
Current assets 29/58 €69,051 €46,982 -€22,069 -32.0%
Amounts receivable within one year 40/41 €15,972 €15,972 = 0.0%
Trade receivables 40 €15,972 €15,972 = 0.0%
Other amounts receivable 41 €0 €0 =
Cash at bank and in hand 54/58 €50,853 €29,894 -€20,959 -41.2%
Deferred charges and accrued income 490/1 €2,226 €1,117 -€1,109 -49.8%
Total equity and liabilities 10/49 €82,033 €76,879 -€5,154 -6.3%
Equity 10/15 €8,872 €9,170 +€298 +3.4%
Contributions 10/11 €4,000 €4,000 = 0.0%
Profit (loss) carried forward 14 €4,872 €5,170 +€298 +6.1%
Amounts payable 17/49 €73,161 €67,709 -€5,453 -7.5%
Amounts payable within one year 42/48 €73,161 €67,709 -€5,453 -7.5%
Financial debts 43 €3 €816 +€813 +27203.3%
Credit institutions 430/8 €3 €816 +€813 +27203.3%
Trade debts 44 €1,980 €1,139 -€842 -42.5%
Suppliers 440/4 €1,980 €1,139 -€842 -42.5%
Taxes, remuneration and social security 45 €16,178 €11,754 -€4,424 -27.3%
Taxes 450/3 €16,178 €11,754 -€4,424 -27.3%
Remuneration and social security 454/9 €0 €0 =
Other amounts payable 47/48 €55,000 €54,000 -€1,000 -1.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,829 €7,248 +€5,419 +296.4%
Other operating charges 640/8 €1,370 €959 -€411 -30.0%
Gross operating margin 9900 €75,112 €77,795 +€2,683 +3.6%
Operating profit (loss) 9901 €71,913 €69,588 -€2,325 -3.2%
Financial income 75/76B €871 €173 -€699 -80.2%
Recurring financial income 75 €871 €173 -€699 -80.2%
Financial charges 65/66B €202 €206 +€3 +1.7%
Recurring financial charges 65 €202 €206 +€3 +1.7%
Profit (loss) for the period before taxes 9903 €72,583 €69,555 -€3,027 -4.2%
Income taxes 67/77 €15,691 €15,257 -€434 -2.8%
Profit (loss) for the period 9904 €56,892 €54,298 -€2,593 -4.6%
Profit (loss) for the period to be appropriated 9905 €56,892 €54,298 -€2,593 -4.6%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.